Work

Combination with Cytotoxic Therapy and Checkpoint Blockade Overcomes Primary Resistance to BCMA Bispecific Antibody Therapy and Leads to Durable Remission of Vk*MYC Multiple Myeloma

Year: 2024

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2024-210917

Authors: Erin W Meermeier, Caleb K Stein, Meaghen Sharik, Megan Du, Yuan Xiao Zhu, Chang-Xin Shi, Yuliza Shotts, Maria Josic, Keith Abayasiriwardana, Natalie Bezman, Timothy Fisher, Kristin Bompiani-Myers, Leif Bergsagel, Marta Chesi

Institutions: Mayo Clinic, Mayo Clinic in Arizona

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405043018

Cites:

Cited by:

Related to: 10